Companies /Healthcare

Abbvie Inc

NYSE: ABBV Drug Manufacturers - General
$274.36
▼ $6.76 (−2.40%) today
Markets closed · 8:03pm ET
24/7 Rating HOLD
12-Month Price Target
$285.27 +1.7% upside

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets →

Current close $280.60
Street consensus $282.61
Ours vs. the Street +0.9%
$250.83Conservative$280.60Current$285.27Our Target$304.60Optimistic
12-Month Projection Historical Optimistic Target Conservative
$210$240$270$300Oct 2025Oct 2027Today$304.60$285.27$250.83
$210$240$270$300Oct 2025Oct 2027Today$304.60$285.27$250.83

Analyst Sentiment

30ANALYSTS
Buy2480%
Hold517%
Sell13%
The Bottom Line

AbbVie is fairly valued at current levels. With our price target of $285.27 suggesting modest upside, the stock appears to be trading near fair value. Consider your portfolio allocation and investment timeline before making a decision.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Strong analyst consensus (bullish)
+4.6%
Earnings Growth
Strong earnings acceleration
+3.0%
Volatility Adjustment
Lower volatility stock
+1.5%
Price Position
Trading near 52-week high
+1.5%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$280$320$360’26’27’28’29’30’31$372.82$332.57$262.67
$280$320$360’26’27’28’29’30’31$372.82$332.57$262.67

Prediction History

ABBV Price Target History Our Target Stock Price
$260$280$300Jul 16Oct 9$282.09$276.45
$260$280$300Jul 16Oct 9$282.09$276.45
$240$270$300May 28Oct 9$282.09$276.45
$240$270$300May 28Oct 9$282.09$276.45
Date Price Target Stock Price Rating Upside
$282.09 $276.45 HOLD +2.0%
$272.04 $262.90 HOLD +3.5%
$272.82 $264.28 HOLD +3.2%
$283.40 $263.96 BUY +7.4%
$277.74 $257.12 BUY +8.0%
$293.11 $256.46 BUY +14.3%
$312.72 $255.48 BUY +22.4%
$311.56 $264.96 BUY +17.6%
Date Price Target Stock Price Rating Upside
$282.09 $276.45 HOLD +2.0%
$272.82 $264.28 HOLD +3.2%
$312.72 $255.48 BUY +22.4%
$299.16 $257.41 BUY +16.2%
$254.69 $246.38 HOLD +3.4%
$236.66 $216.48 BUY +9.3%

Frequently Asked Questions

What is the ABBV stock price prediction for 2030?

Looking ahead to 2030, our model projects ABBV could trade at an average price of $321.46, with a potential range between $241.09 and $401.82. This represents a potential 14.6% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is ABBV a buy, sell, or hold right now?

24/7 Wall St. currently rates ABBV as a HOLD. Near fair value (1.7%) Among Wall Street analysts, 24 rate it Buy, 5 rate it Hold, and 1 rate it Sell.

What is the ABBV stock price target in an optimistic scenario?

Our optimistic scenario for ABBV projects a price of $304.60 over the next 12 months. This represents modest upside of 8.6% from today’s price, suggesting the stock may be fairly valued at current levels even under favorable conditions.

What is the downside risk for ABBV stock?

In our conservative scenario, ABBV could trade as low as $250.83 over the next 12 months, representing a 10.6% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →